Samlyn Capital’s Cano Health, Inc. CANO Stock Holding History

Samlyn Capital’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18,383	Closed	-$15.9M	–	116
2022 Q3	$15.9M	Buy	+18,383	New	+$11.5M	0.3%	64

Other funds holding CANO

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Samlyn Capital's CANO Position: Q4 2022 in Review

Samlyn Capital sold out of Cano Health, Inc. (CANO) in Q4 2022, closing a stake of 61,926 shares — an estimated $53.7M sold.

Samlyn Capital first reported a position in CANO in Q2 2021 and held it in 6 quarters. The position peaked at $53.7M in Q3 2022. 186 funds tracked by Wall St. Rank hold CANO as of Q4 2022.

Samlyn Capital reported no remaining Cano Health, Inc. position as of Q4 2022 after selling out during the quarter.
Samlyn Capital sold 61,926 Cano Health, Inc. shares in Q4 2022, an estimated $53.7M.
Samlyn Capital first reported a position in Cano Health, Inc. in Q2 2021 and held it in 6 quarters.
Samlyn Capital's Cano Health, Inc. position peaked at $53.7M in Q3 2022.
186 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2022.

Based on Samlyn Capital's 13F filing for Q4 2022, filed 14 Feb 2023.